Is There a Role for Anandamide in Cardiovascular Regulation? Insights From Studies of Endocannabinoid Metabolism

American Journal of Physiology - Heart and Circulatory Physiology - United States
doi 10.1152/ajpheart.00433.2005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Physiological Society

Related search

Metabolism of the Endocannabinoid Anandamide: Open Questions After 25 Years

Frontiers in Molecular Neuroscience
Molecular NeuroscienceMolecular BiologyCellular
2017English

Postprandial Energy Metabolism in the Regulation of Body Weight: Is There a Mechanistic Role for Dietary Calcium?

Nutrients
NutritionFood ScienceDietetics
2010English

The Endocannabinoid System, Anandamide and the Regulation of Mammalian Cell Apoptosis

Cell Death and Differentiation
Cell BiologyMolecular Biology
2003English

Blood Pressure Regulation During Bathing: Is There a Cardiovascular Risk?

2012English

Migraine With Atypical Aura: Is There a Role for Cerebral Perfusion Studies?

Developmental Medicine and Child Neurology
Child HealthDevelopmental NeurosciencePediatricsPerinatologyNeurology
2016English

Lipoxin A4 Is an Allosteric Endocannabinoid That Strengthens Anandamide-Induced CB1 Receptor Activation

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

ANGPTL3 Inhibitors ― Their Role in Cardiovascular Disease Through Regulation of Lipid Metabolism ―

Circulation Journal
MedicineCardiovascular MedicineCardiology
2019English

Rheumatic Heart Disease in Africa: Is There a Role for Genetic Studies? : Review Article

Cardiovascular Journal of Africa
MedicineCardiovascular MedicineCardiology
2015English

Obesity and the Endocannabinoid System: Is There Still a Future for CB1 Antagonists in Obesity?

Current obesity reports
Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy